Fritextsökning
Innehållstyper
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
De ska korta vägen till marknaden
Swelife, Medtech4Health och EIT Health Scandinavia samarbetar för att stärka svensk life science och medicinteknik. Målet är att förkorta tiden till marknadsint...
-
Självadministrerad astmabehandling godkänd i USA
Astra Zeneca tillsammans med det amerikanska företaget Amgen har nu fått det självadministrerade astmaläkemedlet Tezspire godkänt i USA.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Stamceller påverkas av A-vitamin
Umeåforskare visar att A-vitamin har effekt på hur benmärgens stamceller utvecklas. Det påverkar i sin tur benmassan i kroppen.
-
Peptider kan bli framtidens läkemedel
Tyska forskare rapporterar ett genombrott i arbetet med att göra små proteiner tillgängliga som läkemedel i pillerform.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Control of blood vessels can treat obesity
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Cell incubator with built-in microscope
InCu-view live is an incubator from Sanyo for cell or embryo culture with documentation functionality.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
New nanotech professor to DTU
The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Hon ska leda A+ Science
Agneta Franksson blir kontraktsforskningsföretagets nya vd
-
Analys av metaboliter hjälp för att skräddarsy behandlingar
Genom att studera kroppens nedbrytningsprodukter, metaboliter, kan behandlingar bättre skräddarsys för patientens specifika behov och förutsättningar. Det säger...
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
Samuel Lagercrantz: Samarbete och samverkan är nyckeln till framgång
Trots att många frågor om covid-19 fortfarande är obesvarade har utvecklingen av läkemedel och vaccin gått otroligt snabbt, skriver Samuel Lagercrantz i en ledare.
BREAKING